Chargement en cours...
B Cell Therapy for Multiple Sclerosis: Entering an Era
Monoclonal antibodies that target CD20 expressing B cells represent an important new treatment option for patients with multiple sclerosis (MS). B cell depleting therapy is highly effective against relapsing forms of the disease, and is also the first treatment approach proven to protect against dis...
Enregistré dans:
| Publié dans: | Ann Neurol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876115/ https://ncbi.nlm.nih.gov/pubmed/29244240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25119 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|